230 related articles for article (PubMed ID: 36419136)
1. UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis.
Zhao L; Kang M; Liu X; Wang Z; Wang Y; Chen H; Liu W; Liu S; Li B; Li C; Chang A; Tang B
J Exp Clin Cancer Res; 2022 Nov; 41(1):330. PubMed ID: 36419136
[TBL] [Abstract][Full Text] [Related]
2. Atypical plant homeodomain of UBR7 functions as an H2BK120Ub ligase and breast tumor suppressor.
Adhikary S; Chakravarti D; Terranova C; Sengupta I; Maitituoheti M; Dasgupta A; Srivastava DK; Ma J; Raman AT; Tarco E; Sahin AA; Bassett R; Yang F; Tapia C; Roy S; Rai K; Das C
Nat Commun; 2019 Mar; 10(1):1398. PubMed ID: 30923315
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of substrate-induced ubiquitin transfer by UBR7-PHD finger, a newly identified histone H2BK120 ubiquitin ligase.
Dasgupta A; Mondal P; Dalui S; Das C; Roy S
FEBS J; 2022 Apr; 289(7):1842-1857. PubMed ID: 34739193
[TBL] [Abstract][Full Text] [Related]
4. The Ubiquitin E3 Ligase TRIM21 Promotes Hepatocarcinogenesis by Suppressing the p62-Keap1-Nrf2 Antioxidant Pathway.
Wang F; Zhang Y; Shen J; Yang B; Dai W; Yan J; Maimouni S; Daguplo HQ; Coppola S; Gao Y; Wang Y; Du Z; Peng K; Liu H; Zhang Q; Tang F; Wang P; Gao S; Wang Y; Ding WX; Guo G; Wang F; Zong WX
Cell Mol Gastroenterol Hepatol; 2021; 11(5):1369-1385. PubMed ID: 33482392
[TBL] [Abstract][Full Text] [Related]
5. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1.
Lignitto L; LeBoeuf SE; Homer H; Jiang S; Askenazi M; Karakousi TR; Pass HI; Bhutkar AJ; Tsirigos A; Ueberheide B; Sayin VI; Papagiannakopoulos T; Pagano M
Cell; 2019 Jul; 178(2):316-329.e18. PubMed ID: 31257023
[TBL] [Abstract][Full Text] [Related]
7. NRF2 DLG Domain Mutations Identified in Japanese Liver Cancer Patients Affect the Transcriptional Activity in HCC Cell Lines.
Haque E; Śmiech M; Łuczyńska K; Bouchard MF; Viger R; Kono H; Pierzchała M; Taniguchi H
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069882
[TBL] [Abstract][Full Text] [Related]
8. Molecular Mechanisms Underlying Hepatocellular Carcinoma Induction by Aberrant NRF2 Activation-Mediated Transcription Networks: Interaction of NRF2-KEAP1 Controls the Fate of Hepatocarcinogenesis.
Haque E; Karim MR; Salam Teeli A; Śmiech M; Leszczynski P; Winiarczyk D; Parvanov ED; Atanasov AG; Taniguchi H
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751080
[TBL] [Abstract][Full Text] [Related]
9. TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway.
Liu Y; Tao S; Liao L; Li Y; Li H; Li Z; Lin L; Wan X; Yang X; Chen L
Nat Commun; 2020 Jan; 11(1):348. PubMed ID: 31953436
[TBL] [Abstract][Full Text] [Related]
10. Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC.
Mattu S; Zavattari P; Kowalik MA; Serra M; Sulas P; Pal R; Puliga E; Sutti S; Foglia B; Parola M; Albano E; Giordano S; Perra A; Columbano A
Cell Mol Gastroenterol Hepatol; 2022; 13(1):113-127. PubMed ID: 34530178
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2.
Kobayashi A; Kang MI; Okawa H; Ohtsuji M; Zenke Y; Chiba T; Igarashi K; Yamamoto M
Mol Cell Biol; 2004 Aug; 24(16):7130-9. PubMed ID: 15282312
[TBL] [Abstract][Full Text] [Related]
12. Comparative subcellular localization of NRF2 and KEAP1 during the hepatocellular carcinoma development in vivo.
Guerrero-Escalera D; Alarcón-Sánchez BR; Arellanes-Robledo J; Cruz-Rangel A; Del Pozo-Yauner L; Chagoya de Sánchez V; Resendis-Antonio O; Villa-Treviño S; Torres-Mena JE; Pérez-Carreón JI
Biochim Biophys Acta Mol Cell Res; 2022 May; 1869(5):119222. PubMed ID: 35093454
[TBL] [Abstract][Full Text] [Related]
13. Sp1 is a substrate of Keap1 and regulates the activity of CRL4A
Siswanto FM; Oguro A; Imaoka S
J Biol Chem; 2021; 296():100704. PubMed ID: 33895141
[TBL] [Abstract][Full Text] [Related]
14. The KEAP1-NRF2 System and Neurodegenerative Diseases.
Uruno A; Yamamoto M
Antioxid Redox Signal; 2023 May; 38(13-15):974-988. PubMed ID: 36930785
[No Abstract] [Full Text] [Related]
15. Molecular Basis of the KEAP1-NRF2 Signaling Pathway.
Suzuki T; Takahashi J; Yamamoto M
Mol Cells; 2023 Mar; 46(3):133-141. PubMed ID: 36994473
[TBL] [Abstract][Full Text] [Related]
16. CAPE and its synthetic derivative VP961 restore BACH1/NRF2 axis in Down Syndrome.
Pagnotta S; Tramutola A; Barone E; Di Domenico F; Pittalà V; Salerno L; Folgiero V; Caforio M; Locatelli F; Petrini S; Butterfield DA; Perluigi M
Free Radic Biol Med; 2022 Apr; 183():1-13. PubMed ID: 35283228
[TBL] [Abstract][Full Text] [Related]
17. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex.
Zhang DD; Lo SC; Cross JV; Templeton DJ; Hannink M
Mol Cell Biol; 2004 Dec; 24(24):10941-53. PubMed ID: 15572695
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases.
Villeneuve NF; Lau A; Zhang DD
Antioxid Redox Signal; 2010 Dec; 13(11):1699-712. PubMed ID: 20486766
[TBL] [Abstract][Full Text] [Related]
19. SLC27A5 deficiency activates NRF2/TXNRD1 pathway by increased lipid peroxidation in HCC.
Gao Q; Zhang G; Zheng Y; Yang Y; Chen C; Xia J; Liang L; Lei C; Hu Y; Cai X; Zhang W; Tang H; Chen Y; Huang A; Wang K; Tang N
Cell Death Differ; 2020 Mar; 27(3):1086-1104. PubMed ID: 31367013
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas9-based genome-wide screening identified novel targets for treating sorafenib-resistant hepatocellular carcinoma: a cross-talk between FGF21 and the NRF2 pathway.
Chen J; Jiang S; Shao H; Li B; Ji T; Staiculescu D; He J; Zhao J; Cai L; Liang X; Xu J; Cai X
Sci China Life Sci; 2022 Oct; 65(10):1998-2016. PubMed ID: 35380342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]